Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cytotherapy|September 13, 2024
CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivityAnton Wesle, Emmanuelle Moraes Ribeiro, Rebekka Schairer, et al.
Autoimmunity|August 24, 2012
Release of lysophospholipid 'find-me' signals during apoptosis requires the ATP-binding cassette transporter A1Christoph Peter, Michaela Waibel, Hildegard Keppeler, et al.
Frontiers in Immunology|August 22, 2018
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate LeukemiaHannes Schmid, Corina Schneidawind, Simona Jahnke, et al.
International Journal of Molecular Sciences|December 17, 2024
Only Infant <i>MLL</i>-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by VolasertibJacqueline Fischer, Estelle Erkner, Pia Radszuweit, et al.
Cancers|May 28, 2020
MAT2A as Key Regulator and Therapeutic Target in <i>MLL</i>r LeukemogenesisKathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler, et al.
Oncogene|August 17, 2019
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr-Stoerzer, et al.
Journal of Cell Science|April 29, 2011
Phagocytosis of dying tumor cells by human peritoneal mesothelial cellsBritta Janina Wagner, Dennis Lindau, Dagmar Ripper, et al.
Autophagy|October 26, 2011
Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy inductionSebastian Alers, Antje S Löffler, Florian Paasch, et al.
Pageof 4